Osprey Medical Inc Share Price and Company Fundamentals
Last traded: Last Friday at 6:10 AM
Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert NG, DyeVert Plus System, and DyeVert Plus EZ Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.
|Primary activities||Development and commercialization of its proprietary DyeVert System, a medical device used for the prevention of Acute Kidney Injury in patients undergoing heart imaging procedures.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||5600 Rowland Road Suite 250 Minnetonka MN 55343 United States|
|Phone / Fax||952 955 8230 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Osprey Medical Inc does not pay dividends.
As of May 2021, following are the company executives and directors listed on Osprey Medical Inc.
|Mr. Michael McCormick||Pres, CEO & Exec. Director||58||612.27k|
|Dr. J. Edward Shapland||Co-Founder|
|Ms. Nancy Ness||VP of Fin. & CFO|
|Mr. Vic Fabano||VP of Operations & IT||58|
|Ms. Melanie Hess||VP of Regulatory Affairs, Compliance & Quality|
|Mr. Doug Schoenberg||VP of Marketing, Education & Reimbursement||50|
|Mr. Brendan T. Case C.P.A., BEc, Grad Dip., MComLaw, CPA, Dip FP||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Osprey Medical Inc is 87.24M and its enterprise value is 23.5M. The enterprise value to revenue ratio of OSP is 14.06.
The OSP's stocks Beta value is 1.36 making it 36% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Osprey Medical Inc (OSP)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Osprey Medical Inc (ASX:OSP) Frequently Asked Questions
1. What is Osprey Medical Inc's Stock Symbol?
Osprey Medical Inc trades on ASX under the ticker symbol "OSP".
2. What is Osprey Medical Inc's stock price today?
One share of OSP stock can currently be purchased for approximately $0.017.
3. How can I contact Osprey Medical Inc?
Osprey Medical Inc's mailing address is 5600 Rowland Road Suite 250 Minnetonka MN 55343 United States. The company can be reached via phone at 952 955 8230.
4. What is Osprey Medical Inc's official website?
The official website of Osprey Medical Inc is http://www.ospreymed.com.
5. Which share registry manages Osprey Medical Inc's stock?
Osprey Medical Inc's stock is managed by LINK MARKET SERVICES LIMITED.